首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1593475

细胞计数市场规模、份额、成长分析、按产品、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Cell Counting Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月10日 | 出版商:

SkyQuest | 英文 189 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球细胞计数市场规模为98亿美元，从2023年的104.7亿美元成长到2031年的177.2亿美元，复合年增长率预计为6.80%。

由于细胞生物学、癌症研究和免疫学等领域的研究重点不断增加，细胞计数市场正在经历强劲成长。促成这一市场扩张的主要因素是个人化医疗需求的不断增长、慢性疾病患者数量的快速增加以及细胞计数技术的持续进步。然而，技术复杂性和缺乏操作这些技术的熟练人员等挑战正在阻碍市场成长。儘管有这些限制，但随着创新技术的引入和细胞疗法的重要性日益增加，产业不断发展，前景仍然乐观。此外，数位技术的整合正在改变细胞计数方法并进一步增加市场潜力。因此，细胞计数市场预计将保持上升趋势，满足医学研究和诊断领域的多样化应用，并最终提高医疗保健结果的品质。

市场概况
消耗品
- 培养基血清试剂
- 检测试剂套件
- 微孔盘
- 配件
- 其他消耗品
装置
- 光强度
- 单模式读卡机
- 多模式读卡器
- 流式细胞仪
- 血液分析仪
- 全自动分析仪
- 半自动血液分析仪
- 细胞计数器
- 自动细胞计数仪
- 血球计数器/手动细胞计数器
- 显微镜

细胞计数市场：依应用分类

市场概况
研究用途
- 癌症研究
- 免疫学研究
- 神经学调查
- 干细胞研究
- 其他研究用途
医疗用途
- 非侵入性产前诊断
- 体外受精
- 循环性肿瘤细胞的检测
工业用途

细胞计数市场：依最终用户划分

市场概况
调查机构
医院和诊断实验室
製药和生物技术公司以及合约研究组织 (CROS)
其他最终用户

细胞计数市场：按地区

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 阿拉伯联合大公国国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Danaher Corporation（US）
Thermo Fisher Scientific（US）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
Bio-Rad Laboratories Inc.（US）
Abbott Laboratories（US）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Corning（US）
Tecan（Switzerland）
Boule Diagnostics AB（Sweden）
Olympus Corporation（Japan）
Horiba（Japan）
Sysmex Corporation（Japan）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche AG（Switzerland）
Luminex Corporation（US）
Nexcelom Bioscience LLC（US）
Tip Biosystems（Singapore）
Logos Biosystems, Inc.（South Korea）

简介目录

Product Code: SQMIG35H2305

Global Cell Counting Market size was valued at USD 9.8 billion in 2022 and is poised to grow from USD 10.47 billion in 2023 to USD 17.72 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The cell counting market is witnessing robust growth driven by the increasing focus on research in areas such as cell biology, cancer research, and immunology. This market expansion is primarily fueled by the rising demand for personalized medicine, the surge in chronic disease cases, and ongoing advancements in cell counting technologies. However, challenges such as technical complexities and a shortage of skilled personnel to operate these technologies present hurdles to market growth. Despite these constraints, the outlook remains positive as the industry evolves with the introduction of innovative technologies and the rising significance of cell-based therapies. Additionally, the integration of digital technologies is transforming cell counting methods, further boosting market potential. As a result, the cell counting market is expected to continue its upward trajectory, accommodating a diverse range of applications in medical research and diagnostics, and ultimately enhancing the quality of healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Counting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Counting Market Segmental Analysis

Global Cell Counting Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Application, the market is segmented into Research Applications, Medical Applications, and Industrial Applications. Based on End User, the market is segmented into Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS), and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Counting Market

The Global Cell Counting market is significantly driven by major advancements in technology, including the development of superior automated cell counters, high-tech flow cytometers, and enhanced imaging systems. These innovations enhance the reliability and efficiency of cell counting processes, thereby increasing demand across various sectors such as clinical diagnostics and research. The improved accuracy and speed of these advanced systems not only facilitate precise cell analysis but also contribute to better clinical outcomes and research efficacy. As healthcare and life sciences continue to emphasize the importance of accurate diagnostics and data-driven research, the demand for advanced cell counting solutions is poised for robust growth.

Restraints in the Global Cell Counting Market

One significant market restraint affecting the Global Cell Counting market is the limited reimbursement options available for certain cell counting systems in various regions. This inadequacy can negatively influence the financial feasibility of adopting advanced technologies, thereby detracting from potential demand. The financial burden on researchers and healthcare providers arising from insufficient reimbursement may deter them from exploring and investing in novel cell counting solutions, ultimately impeding innovation and growth in the sector. As a result, the hesitance to embrace cutting-edge cell counting technologies due to reimbursement issues poses a considerable challenge to market expansion and development.

Market Trends of the Global Cell Counting Market

The Global Cell Counting Market is witnessing a notable trend characterized by a heightened emphasis on assessing cell functionality and viability, moving beyond traditional counting methods. Researchers and clinicians are increasingly recognizing the importance of evaluating cell activity and health, particularly in applications such as drug development, cancer research, and regenerative medicine. This demand is driving innovation in technologies that not only quantify cells but also provide comprehensive insights into cellular behavior. As a result, novel solutions are being developed to enhance the accuracy and efficiency of cell viability assays, thereby expanding the scope of applications and fostering growth within the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Value Chain Analysis
Case Study Analysis

Cell Counting Market by Product

Market Overview
Consumables
- Media, Sera, And Reagents
- Assay Kits
- Microplates
- Accessories
- Other Consumables
Instruments
- Spectrophotometers
- Single-Mode Readers
- Multi-Mode Readers
- Flow Cytometers
- Hematology Analyzers
- Fully Automated Analyzers
- Semi-Automated Hematology Analyzers
- Cell Counters
- Automated Cell Counters
- Hemocytometers/Manual Cell Counters
- Microscopes

Cell Counting Market by Application

Market Overview
Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
Medical Applications
- Noninvasive Prenatal Diagnosis
- In Vitro Fertilization
- Circulating Tumor Cell Detection
Industrial Applications

Cell Counting Market by End User

Market Overview
Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS)
Other End Users

Cell Counting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexcelom Bioscience LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tip Biosystems (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Logos Biosystems, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments